154 related articles for article (PubMed ID: 32117713)
1. Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma.
Chen J; Wang L; Wang F; Liu J; Bai Z
Front Oncol; 2020; 10():37. PubMed ID: 32117713
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide identification of RNA editing in hepatocellular carcinoma.
Kang L; Liu X; Gong Z; Zheng H; Wang J; Li Y; Yang H; Hardwick J; Dai H; Poon RT; Lee NP; Mao M; Peng Z; Chen R
Genomics; 2015 Feb; 105(2):76-82. PubMed ID: 25462863
[TBL] [Abstract][Full Text] [Related]
4. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
Han L; Diao L; Yu S; Xu X; Li J; Zhang R; Yang Y; Werner HMJ; Eterovic AK; Yuan Y; Li J; Nair N; Minelli R; Tsang YH; Cheung LWT; Jeong KJ; Roszik J; Ju Z; Woodman SE; Lu Y; Scott KL; Li JB; Mills GB; Liang H
Cancer Cell; 2015 Oct; 28(4):515-528. PubMed ID: 26439496
[TBL] [Abstract][Full Text] [Related]
5. Liver cancer-specific mutations in functional domains of ADAR2 lead to the elevation of coding and non-coding RNA editing in multiple tumor-related genes.
Li J; Li C; Xu W
Mol Genet Genomics; 2024 Jan; 299(1):1. PubMed ID: 38170228
[TBL] [Abstract][Full Text] [Related]
6. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
[TBL] [Abstract][Full Text] [Related]
7. Identification and Analysis of RNA Editing Events in Ovarian Serous Cystadenoma Using RNA-seq Data.
Wang Y; Song X; Xu T
Curr Gene Ther; 2021; 21(3):258-269. PubMed ID: 33573552
[TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
9. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
10. Evolutionary analysis reveals regulatory and functional landscape of coding and non-coding RNA editing.
Zhang R; Deng P; Jacobson D; Li JB
PLoS Genet; 2017 Feb; 13(2):e1006563. PubMed ID: 28166241
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma.
Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG
J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis.
Behroozi J; Shahbazi S; Bakhtiarizadeh MR; Mahmoodzadeh H
Int J Genomics; 2020; 2020():6493963. PubMed ID: 33415135
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance.
Xiong Y; Yang G; Wang K; Riaz M; Xu J; Lv Z; Zhou H; Li Q; Li W; Sun J; Tao T; Li J
Front Genet; 2020; 11():879. PubMed ID: 32849842
[TBL] [Abstract][Full Text] [Related]
14. 3'UTR polymorphisms of carbonic anhydrase IX determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma.
Hua KT; Liu YF; Hsu CL; Cheng TY; Yang CY; Chang JS; Lee WJ; Hsiao M; Juan HF; Chien MH; Yang SF
Sci Rep; 2017 Jun; 7(1):4466. PubMed ID: 28667334
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation in SIRT1-AS leading to a decreased risk of HCC.
Liu J; Wu W; Jin J
Oncol Rep; 2015 Nov; 34(5):2343-50. PubMed ID: 26324025
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
17. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
[TBL] [Abstract][Full Text] [Related]
18. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
[TBL] [Abstract][Full Text] [Related]
19. Identification of hedgehog signaling as a potential oncogenic driver in an aggressive subclass of human hepatocellular carcinoma: A reanalysis of the TCGA cohort.
Zhao Y; Zhang L; Zhang Y; Meng B; Ying W; Qian X
Sci China Life Sci; 2019 Nov; 62(11):1481-1491. PubMed ID: 31313086
[TBL] [Abstract][Full Text] [Related]
20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
